These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 27405618)

  • 1. Dual antiplatelet and anticoagulant APAC prevents experimental ischemia-reperfusion-induced acute kidney injury.
    Tuuminen R; Jouppila A; Salvail D; Laurent CE; Benoit MC; Syrjälä S; Helin H; Lemström K; Lassila R
    Clin Exp Nephrol; 2017 Jun; 21(3):436-445. PubMed ID: 27405618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with a dual antiplatelet and anticoagulant (APAC) reduces ischemia-reperfusion injury in a mouse model of temporary middle cerebral artery occlusion-implications for neurovascular procedures.
    Denorme F; Frösen J; Jouppila A; Lindgren A; Resendiz-Nieves JC; Manninen H; De Meyer SF; Lassila R
    Acta Neurochir (Wien); 2024 Mar; 166(1):137. PubMed ID: 38485848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice.
    Bonetti NR; Jouppila AS; Saeedi Saravi SS; Cooley BC; Pasterk L; Liberale LL; Gobbato S; Lüscher TF; Camici GG; Lassila RP; Beer JH
    Thromb Res; 2023 Aug; 228():163-171. PubMed ID: 37331119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Functional Pharmacokinetic Profile of APAC, a Novel Intravascular Antiplatelet and Anticoagulant.
    Craige S; Jouppila A; Humphries B; Lassila R
    J Cardiovasc Pharmacol; 2021 Sep; 78(3):453-462. PubMed ID: 34132685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual antiplatelet and anticoagulant (APAC) heparin proteoglycan mimetic with shear-dependent effects on platelet-collagen binding and thrombin generation.
    Chen J; Verni CC; Jouppila A; Lassila R; Diamond SL
    Thromb Res; 2018 Sep; 169():143-151. PubMed ID: 30071479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways.
    Gui D; Huang J; Liu W; Guo Y; Xiao W; Wang N
    Apoptosis; 2013 Apr; 18(4):409-22. PubMed ID: 23325448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats.
    Puri N; Mohey V; Singh M; Kaur T; Pathak D; Buttar HS; Singh AP
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):361-8. PubMed ID: 26728617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of clinically significant pharmacological interactions between ticagrelor and enoxaparin or unfractionated heparin in healthy subjects.
    Teng R; Butler K
    J Clin Pharm Ther; 2012 Dec; 37(6):704-11. PubMed ID: 22747575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe
    Bot I; Delfos L; Hemme E; Bernabé Kleijn MNA; van Santbrink PJ; Foks AC; Kovanen PT; Jouppila A; Lassila R
    Atherosclerosis; 2024 Oct; 397():118567. PubMed ID: 39243663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell-derived heparin proteoglycans as a model for a local antithrombotic.
    Lassila R; Jouppila A
    Semin Thromb Hemost; 2014 Nov; 40(8):837-44. PubMed ID: 25393636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study.
    Balkanay OO; Goksedef D; Omeroglu SN; Ipek G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):209-14. PubMed ID: 25392341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treprostinil, a prostacyclin analog, ameliorates renal ischemia-reperfusion injury: preclinical studies in a rat model of acute kidney injury.
    Ding M; Tolbert E; Birkenbach M; Akhlaghi F; Gohh R; Ghonem NS
    Nephrol Dial Transplant; 2021 Jan; 36(2):257-266. PubMed ID: 33156922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of N-desulfated heparin on hepatic/renal ischemia reperfusion injury in rats.
    Zhou T; Chen JL; Song W; Wang F; Zhang MJ; Ni PH; Geng JG
    World J Gastroenterol; 2002 Oct; 8(5):897-900. PubMed ID: 12378638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor simvastatin treatment prevents ischemia-reperfusion and acute kidney injury by preserving microvascular barrier function.
    Tuuminen R; Nykänen AI; Saharinen P; Gautam P; Keränen MA; Arnaudova R; Rouvinen E; Helin H; Tammi R; Rilla K; Krebs R; Lemström KB
    Am J Transplant; 2013 Aug; 13(8):2019-34. PubMed ID: 23773358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of kallistatin on oxidative stress and inflammation on renal ischemia-reperfusion injury in mice.
    Zhou S; Sun Y; Zhuang Y; Zhao W; Chen Y; Jiang B; Guo C; Zhang Z; Peng H; Chen Y
    Curr Vasc Pharmacol; 2015; 13(2):265-73. PubMed ID: 25654330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter.
    Arcangeli A; Rocca B; Salvatori G; Ciancia M; De Cristofaro R; Antonelli M
    Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reno-protective effects of TAK-242 on acute kidney injury in a rat model.
    Mohammad BI; Raheem AK; Hadi NR; Jamil DA; Al-Aubaidy HA
    Biochem Biophys Res Commun; 2018 Sep; 503(1):304-308. PubMed ID: 29902463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infusion of IL-10-expressing cells protects against renal ischemia through induction of lipocalin-2.
    Jung M; Sola A; Hughes J; Kluth DC; Vinuesa E; Viñas JL; Pérez-Ladaga A; Hotter G
    Kidney Int; 2012 May; 81(10):969-982. PubMed ID: 22278021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of N-(p-amylcinnamoyl) anthranilic acid, phospholipase A
    Çakır M; Tekin S; Taşlıdere A; Çakan P; Düzova H; Gül CC
    J Cell Biochem; 2019 Mar; 120(3):3822-3832. PubMed ID: 30259992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
    Jackson CV; Crowe VG; Frank JD; Wilson HC; Coffman WJ; Utterback BG; Jakubowski JA; Smith GF
    J Pharmacol Exp Ther; 1992 May; 261(2):546-52. PubMed ID: 1578372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.